Picture of Renerve logo

RNV Renerve Income Statement

0.000.00%
au flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Annual income statement for Renerve, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.

2022
June 30th
2023
June 30th
2024
June 30th
Period Length:12 M12 M12 M
Source:ARSARSARS
Standards:
AAS
AAS
AAS
Status:FinalFinalFinal
Revenue
Total Revenue00.1280.177
Cost of Revenue
Gross Profit0.177
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Other Operating Expenses
Total Operating Expenses1.781.983.16
Operating Profit-1.78-1.86-2.98
Total Net Non Operating Interest Income / Expense
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes-1.76-1.8-2.98
Provision for Income Taxes
Net Income After Taxes-1.76-1.8-2.98
Net Income Before Extraordinary Items
Net Income-1.76-1.8-2.98
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income-1.76-1.8-2.98
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS-0.012-0.013-0.021